SCHEMBL21722471

SCHEMBL21722471

Cc1ccn(-c2nccnc2C(N)=O)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 3/20 0.40
▸ MAPT P10636 2/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ TGFBR1 P36897 1/20 0.39
▸ NPC1 O15118 2/20 0.38
▸ ATM Q13315 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ NOS1 P29475 1/20 0.38
▸ ADORA2A P29274 5/20 0.36
▸ TDO2 P48775 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ ADORA3 P0DMS8 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ ADORA2B P29275 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ KAT2B Q92831 1/20 0.36
▸ HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17778186 0.73 ADORA2A (0.39) RAB9AMAPTKDM4EALDH1A1GAA
SCHEMBL21722361 0.72 HCRTR2 (0.44) MAPTKDM4EALDH1A1GAAADORA2A
SCHEMBL21722321 0.70 KDM5A (0.43) KDM4EALDH1A1ADORA2ALMNAADORA3
SCHEMBL3657454 0.69 HTT (0.53) RAB9AMAPTKDM4EALDH1A1GAA
SCHEMBL28309777 0.68 ADORA3 (0.34) MAPTKDM4EALDH1A1SMN1; SMN2ADORA2A
SCHEMBL15758648 0.68 KCNJ1 (0.46) RAB9AMAPTALDH1A1
SCHEMBL3989249 0.67 RAB9A (0.39) RAB9AMAPTKDM4EALDH1A1GAA
SCHEMBL2492969 0.66 TSHR (0.48) MAPTKDM4EALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL1463944 0.66 MKNK1 (0.42) MAPTKDM4EALDH1A1ADORA2ALMNA
SCHEMBL2310300 0.66 MKNK1 (0.42) MAPTKDM4EALDH1A1ADORA2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3837250-A1 PYRAZINE COMPOUNDS AND USES THEREOF DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD (CN) 2021-06-23 — — EP claimed
WO-2020035052-A1 PYRAZINE COMPOUNDS AND USES THEREOF DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. (CN) 2020-02-20 — — WO claimed
EP-3837250-A1 PYRAZINE COMPOUNDS AND USES THEREOF DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD (CN) 2021-06-23 — — EP disclosed
CN-112279837-A Pyrazine compounds and uses thereof 迪哲(江苏)医药股份有限公司 2021-01-29 — — CN disclosed
WO-2020035052-A1 PYRAZINE COMPOUNDS AND USES THEREOF DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. (CN) 2020-02-20 — — WO disclosed
Send feedback